Pensar Medical

Executive Summary

Pensar Medical is a US-based private medical device company specializing in advanced negative pressure wound therapy (NPWT) systems. Founded in 2019 and headquartered in Salt Lake City, the company develops and commercializes portable, single-use, and traditional NPWT devices aimed at accelerating wound healing, reducing complications, and providing cost-effective solutions for clinicians and patients. Its product portfolio covers a broad spectrum of acute and chronic wounds in surgical, orthopedic, and home care settings. Despite being a relatively young entrant in the competitive wound care market, Pensar Medical leverages its focus on innovation and portability to differentiate itself. The company has not disclosed funding or valuation details, suggesting it may be in early commercialization or development stage. The lack of publicly available pipeline or regulatory milestones adds uncertainty, but its targeted addressable market and clear value proposition position it for potential growth if it successfully navigates regulatory pathways and commercialization strategies.

Upcoming Catalysts (preview)

• Q4 2026FDA 510(k) clearance for next-generation NPWT device70% success
• Q2 2026Strategic partnership with a major hospital network for distribution50% success
• Q3 2026Launch of disposable single-use NPWT system60% success